13F Data
13F filer · CIK 2043476

B Group, Inc.

DALLAS, TX · filing since Q4 2024 · last filing Aug 14, 2026
Reported value
$213.0M
+$78.1M vs prior
Positions
19
New / sold out
2 / 3
Added / reduced
5 / 1
Turnover
2.2%
buys $59.3M · sells $3.7M
Top-10 weight
79.5%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewINVESCO QQQ TRPUT+50,000–+$36.8M
NewFAETH THERAPEUTICS INC+610,169–+$15.3M
AddedNRX PHARMACEUTICALS INC+1,091,767+36.4%+$4.5M
AddedAURA BIOSCIENCES INC+166,667+27.9%+$1.2M
AddedSTRUCTURE THERAPEUTICS INC+12,500+9.8%+$670.9K
AddedFOGHORN THERAPEUTICS INC+98,000+96.1%+$478.2K
AddedADMA BIOLOGICS INC+55,000+1.7%+$460.4K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedSPYRE THERAPEUTICS INC-30,000-30.0%$-2.7M
Sold outAPOGEE THERAPEUTICS INC-7,500-100.0%$-631.3K
Sold outSOLENO THERAPEUTICS INC-7,500-100.0%$-251.1K
Sold outREPLIMUNE GROUP INC-26,000-100.0%$-198.9K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2024: $163.6MQ1 2025: $116.7MQ2 2025: $129.9MQ3 2025: $135.9MQ4 2025: $135.4MQ1 2026: $134.9MQ2 2026: $213.0M
Q4 2024Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1INVESCO QQQ TRPUTPUT50,000$36.8M17.29%
2ADMA BIOLOGICS INCCOM3,262,542$27.3M12.82%
3PALISADE BIO INCCOM11,414,285$23.9M11.20%
4NRX PHARMACEUTICALS INCCOM NEW4,091,767$16.7M7.86%
5FAETH THERAPEUTICS INCCOM NEW610,169$15.3M7.16%
6TAYSHA GENE THERAPIES INCCOM SHS1,800,556$12.3M5.76%
7PRAXIS PRECISION MEDICINES ICOM NEW33,237$11.1M5.22%
8CELLECTIS S ASPON ADS3,281,501$9.8M4.62%
9ZAI LAB LTDADR450,646$8.6M4.02%
10STRUCTURE THERAPEUTICS INCSPONSORED ADS140,000$7.5M3.53%
9 more rows. Subscribe for $29/month to see every row, download the data and use the API.